RecruitingPhase 3NCT05625724

Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology

Studying Preeclampsia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Toulouse
Principal Investigator
Christophe VAYSSIERE, MD
University Hospital, Toulouse
Intervention
Aspirin(drug)
Enrollment
1164 target
Eligibility
18 years · FEMALE
Timeline
20232026

Study locations (21)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05625724 on ClinicalTrials.gov

Other trials for Preeclampsia

Additional recruiting or active studies for the same condition.

See all trials for Preeclampsia

← Back to all trials